These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37275803)

  • 1. A Clinical-Mycological Study of Dermatophytosis in Western India with Focus on Antifungal Drug Resistance as a Factor in Recalcitrance.
    Shah SR; Vyas HR; Shah BJ; Jangid NC; Choudhary A; Gehlawat T; Mistry D; Joshi R
    Indian J Dermatol; 2023; 68(2):234. PubMed ID: 37275803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinico-Mycological Profile of Treatment-Naïve, Chronic, Recurrent and Steroid-Modified Dermatophytosis at a Tertiary Care Centre in Eastern India: An Institution-Based Cross-SectionalStudy.
    Saha I; Podder I; Chowdhury SN; Bhattacharya S
    Indian Dermatol Online J; 2021; 12(5):714-721. PubMed ID: 34667758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?
    Sardana K; Kaur R; Arora P; Goyal R; Ghunawat S
    Indian Dermatol Online J; 2018; 9(2):90-95. PubMed ID: 29644192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Clinico-mycological, Antifungal Drug Sensitivity and Therapeutic Study of Extensive Dermatophytosis in Coastal Andhra Pradesh.
    Vanapalli S; Turpati NR; Gopal KVT; Krishnam Raju PV; Devi BG
    Indian Dermatol Online J; 2022; 13(6):747-753. PubMed ID: 36386757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study.
    Tahiliani S; Saraswat A; Lahiri AK; Shah A; Hawelia D; Shah GK; Girdhar M; Rao PN; Raghav PA; Agarwal P; Kharkar RD; Gupta RP; Udare S; Hegde S; Haldar S
    Indian J Dermatol Venereol Leprol; 2021; 87(6):800-806. PubMed ID: 34160163
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Singh SK; Patwa DK; Tilak R; Das A; Singh TB
    Indian J Dermatol Venereol Leprol; 2019; 85(4):388-392. PubMed ID: 30950409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: Genomic insights and resistance profile.
    Singh A; Masih A; Monroy-Nieto J; Singh PK; Bowers J; Travis J; Khurana A; Engelthaler DM; Meis JF; Chowdhary A
    Fungal Genet Biol; 2019 Dec; 133():103266. PubMed ID: 31491507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
    Singh S; Chandra U; Anchan VN; Verma P; Tilak R
    Br J Dermatol; 2020 Nov; 183(5):840-846. PubMed ID: 32538466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India.
    Pathania S; Rudramurthy SM; Narang T; Saikia UN; Dogra S
    Indian J Dermatol Venereol Leprol; 2018; 84(6):678-684. PubMed ID: 30058568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).
    Rengasamy M; Shenoy MM; Dogra S; Asokan N; Khurana A; Poojary S; Jayaraman J; Valia AR; Sardana K; Kolalapudi S; Marfatia Y; Rao PN; Bhat RM; Kura M; Pandhi D; Barua S; Kaushal V
    Indian Dermatol Online J; 2020; 11(4):502-519. PubMed ID: 32832435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Road Less Traveled: E-test Method for Antifungal Susceptibility Testing in Trichophyton mentagrophyte Isolates Among Patients Presenting With Dermatophytosis at a Tertiary Healthcare Center in North India.
    Maurya K; Raj N; Kumar Singh A; Das A; Sen M; Garg J; Agarwal J
    Cureus; 2024 Jun; 16(6):e62047. PubMed ID: 38989328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological Trends and Clinicomycological Profile of Chronic Dermatophytosis: A Descriptive Study From South India.
    Rajamohanan R; Raj R; Chellam J; Rengasamy M
    Indian J Dermatol; 2021; 66(4):445. PubMed ID: 34759422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center.
    Mahajan S; Tilak R; Kaushal SK; Mishra RN; Pandey SS
    Indian J Dermatol Venereol Leprol; 2017; 83(4):436-440. PubMed ID: 28540871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Dermatophytosis: Clinico-Mycological Determinants and Antifungal Susceptibility Pattern.
    Sooriya S; Jayapalan S; Mini G; Manjusree S; Nandakumar L
    Indian J Dermatol; 2021; 66(3):329. PubMed ID: 34446965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical study on antifungal drug resistance among cases of dermatophytosis in patients reporting to multiple tertiary care hospitals.
    Singh Gill J; Chatterjee M; Baveja S; Hazra N; Tandel K; R V; Verma R
    Med J Armed Forces India; 2023 Dec; 79(Suppl 1):S244-S249. PubMed ID: 38144609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the in vitro susceptibility pattern of clinical isolates of Trichophyton mentagrophytes and Trichophyton rubrum in Santiago, Chile].
    Díaz Jarabrán MC; Díaz González P; Espinoza Rodríguez J; Carrillo Muñoz AJ
    Rev Iberoam Micol; 2015; 32(2):83-7. PubMed ID: 24794211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species Distribution and Antifungal Susceptibility Profile of Dermatophytes from a Tertiary Care Centre in North India.
    Kumar MB; Gulati N; Chander J; Singla N; Bhalla M; Nayyar C; Sharma S; Kaur M
    J Lab Physicians; 2022 Dec; 14(4):449-455. PubMed ID: 36531552
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A).
    Barros MEDS; Santos DA; Hamdan JS
    J Med Microbiol; 2007 Apr; 56(Pt 4):514-518. PubMed ID: 17374893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terbinafine susceptibility and genotypic heterogeneity in clinical isolates of Trichophyton mentagrophytes by random amplified polymorphic DNA (RAPD).
    Alipour M; Mozafari NA
    J Mycol Med; 2015 Mar; 25(1):e1-9. PubMed ID: 25649232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial.
    Choudhary S; Bisati S; Singh A; Koley S
    Indian J Dermatol; 2013 Nov; 58(6):457-60. PubMed ID: 24249898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.